COVID-19 in patients with lung cancer is a research paper published in Annals of Oncology (2020). On theSindex it has a DataRank of 0.840. It has been cited 270 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.840
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: R01 AI081848
NCI NIH HHS
Grant: R01 CA230745
NCI NIH HHS
Grant: T32 CA009207
NCATS NIH HHS
Grant: UL1 TR000457
NIAID NIH HHS
Grant: HHSN272201400008C
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA230267
NCI NIH HHS
Grant: R25 CA020449
NCI NIH HHS
Grant: R01 CA240924
NCATS NIH HHS
Grant: UL1 TR002384
National Cancer Institute
Damon Runyon Cancer Research Foundation
National Institutes of Health
FWCI
17.60
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea
Additional file 1 of Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea